Regulation of T cell development and maturation by NKAP

NKAP 对 T 细胞发育和成熟的调节

基本信息

  • 批准号:
    8204895
  • 负责人:
  • 金额:
    $ 37.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-01-15 至 2014-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): T cell activation involves the integration of several signals. In addition to antigen specific signaling through the T cell receptor (TCR) and costimulatory signaling through molecules such as CD28, signaling through additional molecules including the transmembrane receptor Notch are critical at many stages of T cell activation and development. To identify novel molecules that regulate T cell activation, we used a genetic approach to rescue the T cell activation defect in a Jurkat mutant cell line by retroviral expression of a leukocyte library. In our initial screen, we found that retroviral expression of NKAP complemented the defect in one Jurkat mutant cell line and restored T cell activation. We have demonstrated that NKAP is a novel negative regulator of Notch signaling that associates with CIR, which is part of the Notch co-repressor complex. To determine the function of NKAP in vivo, we generated mice with a floxed NKAP allele. Lck-cre NKAP conditional knockout mice have a severe block in ??T cell development at the DN3/2-selection checkpoint, although ??T cell development proceeds normally. Interestingly, mice deficient in either NcoR or mSin3a, two generic components of transcriptional corepressor complexes, also have a DN3 block during T cell development, indicating that epigenetic changes are required as cells pass the ?-selection checkpoint to become DP T cells. As predicted, examination of three Notch target genes, CD25, Deltex1 and Hes1 by QPCR demonstrated that NKAP lck-cre cKO DP T cells had increases in gene expression by 8- to 20-fold, proving that the NKAP functions as a negative regulator of Notch signaling in vivo, and is required for T cell development. Analysis of T cell development in CD4-cre NKAP cKO mice demonstrates a block within SP thymocytes as they progress from semimature to mature. In addition, there are decreased numbers of T cells in the periphery in CD4-cre NKAP cKO mice, and these naive T cells express markers consistent with being recent thymic emigrants, indicating that NKAP also plays a critical role in T cell maturation. This proposal will focus on understanding the function of NKAP during T cell development and maturation, to uncover how altered gene regulation in the absence of NKAP alters T cell development and to define the mechanism whereby loss of NKAP leads to upregulation of Notch target genes. Specific Aim #1: Regulation of T cell development and maturation by NKAP Specific Aim #2: Mechanism of altered gene expression in the absence of NKAP PUBLIC HEALTH RELEVANCE: T cells are critical to proper generation of the immune response, as failure to produce T cells results in severe immune deficiency. Mice deficient in the protein NKAP have a severe block in the generation of T cells. This proposal will focus on understanding how NKAP regulates T cell development and maturation.
描述(由申请人提供):T细胞激活涉及多个信号的整合。除了通过T细胞受体(TCR)的抗原特异性信号和通过CD28等分子的共刺激信号外,通过包括跨膜受体Notch在内的其他分子的信号传导在T细胞激活和发育的许多阶段都是至关重要的。为了确定调节T细胞激活的新分子,我们使用遗传方法通过白细胞文库的逆转录病毒表达来挽救Jurkat突变细胞系中的T细胞激活缺陷。在我们最初的筛选中,我们发现NKAP的逆转录病毒表达补充了一个Jurkat突变细胞系的缺陷,并恢复了T细胞的激活。我们已经证明NKAP是Notch信号的一种新的负调节因子,与CIR相关,后者是Notch共抑制因子复合物的一部分。为了确定NKAP在体内的功能,我们制造了带有固定NKAP等位基因的小鼠。Lck-cre NKAP条件敲除小鼠在??T细胞在dn3 /2选择检查点发育,尽管??T细胞的发育正常进行。有趣的是,缺乏nor或mSin3a(两种转录辅助抑制因子复合物的通用成分)的小鼠在T细胞发育过程中也有DN3阻滞,这表明细胞通过?-选择检查点变成DP T细胞。正如预测的那样,通过QPCR检测三个Notch靶基因CD25、Deltex1和Hes1,发现NKAP lck-cre cKO DP T细胞的基因表达增加了8- 20倍,证明NKAP在体内作为Notch信号的负调控因子,是T细胞发育所必需的。对CD4-cre NKAP cKO小鼠T细胞发育的分析表明,SP胸腺细胞在从半成熟到成熟的过程中存在阻滞。此外,CD4-cre NKAP cKO小鼠外周T细胞数量减少,这些幼稚T细胞表达与新近胸腺迁移一致的标记物,表明NKAP在T细胞成熟中也起着关键作用。本研究将重点了解NKAP在T细胞发育和成熟过程中的功能,揭示NKAP缺失时基因调控的改变如何改变T细胞发育,并确定NKAP缺失导致Notch靶基因上调的机制。特异性目标#1:NKAP对T细胞发育和成熟的调控特异性目标#2:NKAP缺失时基因表达改变的机制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Virginia Smith Shapiro其他文献

Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP.
激活的 T 细胞和 AP-1 的核因子不足以激活 IL-2 启动子:RE/AP 上调 CD28 的必要条件。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Virginia Smith Shapiro;M. Mollenauer;Arthur Weiss
  • 通讯作者:
    Arthur Weiss
The nutrient-sensing Rag-GTPase complex in B cells controls humoral immunity via TFEB/TFE3-dependent mitochondrial fitness
B 细胞中的营养感应 Rag-GTP 酶复合物通过依赖 TFEB/TFE3 的线粒体适应性来控制体液免疫
  • DOI:
    10.1038/s41467-024-54344-5
  • 发表时间:
    2024-11-23
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Xingxing Zhu;Yue Wu;Yanfeng Li;Xian Zhou;Jens O. Watzlawik;Yin Maggie Chen;Ariel L. Raybuck;Daniel D. Billadeau;Virginia Smith Shapiro;Wolfdieter Springer;Jie Sun;Mark R. Boothby;Hu Zeng
  • 通讯作者:
    Hu Zeng

Virginia Smith Shapiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Virginia Smith Shapiro', 18)}}的其他基金

Altered TCR signaling in anergy
无能状态下 TCR 信号传导的改变
  • 批准号:
    10750486
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
Training Program in Immunology
免疫学培训计划
  • 批准号:
    10493678
  • 财政年份:
    2022
  • 资助金额:
    $ 37.4万
  • 项目类别:
Training Program in Immunology
免疫学培训计划
  • 批准号:
    10650170
  • 财政年份:
    2022
  • 资助金额:
    $ 37.4万
  • 项目类别:
Regulation of B cell development by ABCB7
ABCB7 对 B 细胞发育的调节
  • 批准号:
    10374116
  • 财政年份:
    2021
  • 资助金额:
    $ 37.4万
  • 项目类别:
Regulation of gene expression by HDAC3
HDAC3 对基因表达的调节
  • 批准号:
    10455700
  • 财政年份:
    2020
  • 资助金额:
    $ 37.4万
  • 项目类别:
Regulation of gene expression by HDAC3
HDAC3 对基因表达的调节
  • 批准号:
    10225415
  • 财政年份:
    2020
  • 资助金额:
    $ 37.4万
  • 项目类别:
Regulation of gene expression by HDAC3
HDAC3 对基因表达的调节
  • 批准号:
    10667604
  • 财政年份:
    2020
  • 资助金额:
    $ 37.4万
  • 项目类别:
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
  • 批准号:
    10308083
  • 财政年份:
    2019
  • 资助金额:
    $ 37.4万
  • 项目类别:
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
  • 批准号:
    10529298
  • 财政年份:
    2019
  • 资助金额:
    $ 37.4万
  • 项目类别:
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
  • 批准号:
    9913027
  • 财政年份:
    2019
  • 资助金额:
    $ 37.4万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.4万
  • 项目类别:
    Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
    Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
    Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 37.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了